ERBB2 and cancer: The aim of the current study is to investigate if MALAT1 will give the same pattern of expression in TAMs of the hormonal, HER2+, and TNBC, highlighting that its role in cancer is still controversial whether it is an oncogenic or a tumor suppressor lncRNA.